Treatment of hyperlipidaemias. Current avenues and new horizons.
There is now conclusive evidence that lowering cholesterol reduces heart disease. This article describes the use of current lipid lowering drugs and the new HMG CoA reductase inhibitors and fibrates.
Janus
E D
ED
D002792:Cholestyramine Resin / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control; D015248:Gemfibrozil / Q000627:therapeutic use; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000178:diet therapy / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*
D000960:Hypolipidemic Agents; D002792:Cholestyramine Resin; D006903:Hydroxymethylglutaryl CoA Reductases; D015248:Gemfibrozil